Studies of Soluble Transplantation and Tumor Antigens

  • Lloyd W. Law
  • Ettore Appella
Part of the Cancer book series (C, volume 4)


Considerable progress has been made in the last 15 years in solubilizing and purifying transplantation antigens (H-2) of the mouse. Until recently, adequate biological assays for activity of solubilized materials were not performed; thus activity was measured principally in terms of inhibition of complementdependent cytotoxicity of lymphoid cells or inhibition of hemagglutination using specially prepared antisera against known determinants. Neither assay is a measure of completeness of antigen; haptenic or nonantigenic fragments may be detected as well as definitive determinants. Recently, newer methods—for example, the use of nonionic detergents—have been used to solubilize H-2 antigens; these so far have precluded adequate biological testing because of the nature of the solubilized material.


Tumor Antigen Tumor Rejection Soluble Antigen Crude Membrane Transplantation Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ankerst, J., Steele, G., Jr., and Sjögren, H. O., 1974, Cross-reacting tumor-associated antigen(s) of adenovirus type 9-induced fibroadenomas in rats, Cancer Res. 34:1794.PubMedGoogle Scholar
  2. Appella, E., Henriksen, O., Natori, T., Tanigaki, N., Law, L. W., and Pressman, D., 1975, Basic structure of mouse histocompatibility antigens, Transplant. Proc. VII: 191.Google Scholar
  3. Baldwin, R. W., and Moore, M., 1969, Isolation of membrane-associated tumor-specific antigen from an aminoazo-dye-induced rat hepatoma, Int. J. Cancer 4:753.PubMedCrossRefGoogle Scholar
  4. Baldwin, R. W., Glaves, D., and Vose, B. M., 1972a, Embryonic antigen expression in chemically induced rat hepatomas and sarcomas, Int. J. Cancer 10:233.PubMedCrossRefGoogle Scholar
  5. Baldwin, R. W., Price, M.R., and Robins, R. A., 1972b, Blocking of lymphocyte mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes, Nature New Biol. 238:185.PubMedCrossRefGoogle Scholar
  6. Baldwin, R. W., Embleton, M. J., and Moore, M., 1973, Immunogenicity of rat hepatoma membrane fractions, Br. J. Cancer 28:389.PubMedCrossRefGoogle Scholar
  7. Blasecki, J. W., and Tevethia, S. S., 1973, In vitro assay of cellular immunity to tumor-specific antigen(s) of virus-induced tumors by macrophage migration inhibition, J. Immunol. 110:590.PubMedGoogle Scholar
  8. Brannen, G. E., Adams, J. S., and Santos, G. W., 1974, Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with 3 preparations of soluble antigens, J. Natl. Cancer Inst. 53:165.PubMedGoogle Scholar
  9. Bystryn, J. S., Schenkein, I., Baur, S., and Uhr, J. W., 1974, Partial isolation and characterization of antigen(s) associated with murine melanoma, J. Natl. Cancer Inst. 52:1263.PubMedGoogle Scholar
  10. Chang, K. S. S., Law, L. W., and Appella, E., 1975, Distinction between tumor specific transplantation antigen and virion antigens in solubilized products from membranes of virus-induced leukemic cells, Int. J. Cancer 15:483.PubMedCrossRefGoogle Scholar
  11. Cullen, S. E., and Nathenson, S. G., 1971, Distribution of H-2 alloantigenic specificities on radiolabeled papain-solubilized antigen fragments, J. Immunol. 107:563.PubMedGoogle Scholar
  12. Cullen, S. E., Schwartz, B. D., Nathenson, S. G., and Cherry, M., 1972, The molecular basis of codominant expression of the histocompatibility-2 genetic region, Proc. Natl. Acad. Sci. U.S.A. 69:1394.PubMedCrossRefGoogle Scholar
  13. Dean, J. H., Mccoy, J. L., Lewis, D., Appella, E., and Law, L. W. 1975, Studies of lymphocyte stimulation by intact tumor cell and solubilized tumor antigen. Int. J. Cancer (in press).Google Scholar
  14. Drapkin, M. S., Appella, E., and Law, L. W., 1974, Immunogenic properties of soluble tumor-specific transplantation antigen induced by simian virus 40, J. Natl. Cancer Inst. 52:259.PubMedGoogle Scholar
  15. Hauschka, T. S., 1973, Tumor immunity, in: Principles of Immunology (N. R. Rose, F. Malgrom, and C. J. von Oss, eds.), pp. 417–438, Macmilan, New York.Google Scholar
  16. Hess, M., and Davies, D. A., 1974, Basic structure of mouse histocompatibility antigens, Eur. J. Biochem. 41:1.PubMedCrossRefGoogle Scholar
  17. Hollinshead, A., and Alford, T. C., 1969, Identification of a soluble transplantation antigen from the membrane fraction of adenovirus tumour cells, J. Gen. Virol. 5:411.CrossRefGoogle Scholar
  18. Hollinshead, A., Mccammon, J. R., and Yohn, D. S., 1972, Immunogenicity of a soluble membrane antigen from adenovirus-12 induced tumor cells demonstrated in inbred hamsters (PD-4), Can. J. Microbiol. 18:1365.PubMedCrossRefGoogle Scholar
  19. Holmes, E. C., Kahan, B. O., and Morton, D. L., 1970, Soluble tumor-specific transplantation antigens from induced guinea pig sarcomas, Cancer 25:373.PubMedCrossRefGoogle Scholar
  20. Howard, J. G., Michie, D., and Woodruff, M. F. A., 1962, in: Transplantation (G. E. W. Wostenholme and M. P. Cameron, eds.), pp. 138–160, Little, Brown, Boston.Google Scholar
  21. Howell, S. B., Dean, J. H., Esber, E. C., and Law, L. W., 1974, Cell interactions in adoptive immune rejection of a syngeneic tumor, Int. J. Cancer 14:662.PubMedCrossRefGoogle Scholar
  22. Jolles, P., Schoentgen, F., Halle-Pannenko, O., and Martyre, M. C., 1970, Purification of soluble transplantation antigens by isoelectric focusing, FEBS Lett. 8:167.PubMedCrossRefGoogle Scholar
  23. Klein, J., and Schreffler, D. C., 1972, Evidence supporting a two-gene model for the H-2 histocompatibility system of the mouse, J. Exp. Med. 135:924.PubMedCrossRefGoogle Scholar
  24. Law, L. W., and Appella, E., 1973, Immunogenic properties of solubilized tumour antigen from an RNA virus transformed neoplasm, Nature (London) 243:83.CrossRefGoogle Scholar
  25. Law, L. W., and Takemoto, K. K., 1973, Specific transplantation antigens of murine neoplasms induced by visna and progressive pneumonia viruses, J. Natl. Cancer Inst. 50:1075.PubMedGoogle Scholar
  26. Law, L. W., Appella, E., Wright, P. W., and Strober, S., 1971, Immunologic enhancement of allogeneic tumor growth with soluble histocompatibility-2 antigens, Proc. Natl. Acad. Sci. U.S.A. 68:3078.PubMedCrossRefGoogle Scholar
  27. Law, L. W., Appella, E., Strober, S., Wright, P. W., and Fischetti, T., 1972, Induction of immunological tolerance to soluble histocompatibility-2 antigens of mice, Proc. Natl. Acad. Sc:. U.S.A. 69:1858.CrossRefGoogle Scholar
  28. Law, L. W., Appella, E., Cohen, J., and Dean, J. H., 1973, Reactivity of lymphoid cells from mice Immorally tolerant to histocompatibility antigens, Nature New Biol. 246:174.PubMedGoogle Scholar
  29. Law, L. W., Appella, E., and Chang, K. S. S., 1975, Biologic effects of solubilized and tumor specific antigens, Transplant. Proc. VII:233.Google Scholar
  30. Law, L. W., Appella, E., Cohen, J. M., and Wright, P. W., 1974, Role of serum factors from tolerant mice in blocking and in immunologic enhancement, Transplantation 18:14.PubMedCrossRefGoogle Scholar
  31. Law, L. W., Appella, E., Strober, S., Wright, P. W., and Fischetti, T., 1974b, Soluble transplantation antigens: Further studies of their tolerogenic properties, Transplantation 18:487.Google Scholar
  32. Leonard, E. J., Meltzer, M. S., Borsos, T., and Rapp, H. J., 1972, Properties of tumor-specific antigen solubilized by hypertonic KCl, in: Conference on Immunology of Carcinogenesis, Natl. Cancer Inst. Monogr. 35:129.PubMedGoogle Scholar
  33. Leonard, E. J., Meltzer, M. S., Borsos, T., and Rapp, H. J., 1974, Immunogenicity of soluble tumor-specific antigen, in: Immunological Aspects of Neoplasia: Proceedings of the 26th Annual Symposium on Fundamental Research, Vol. 26, Williams and Wilkins, Baltimore.Google Scholar
  34. Lieberman, R., Paul, W. E., Humphrey, W., and Stimpfling, J. H., 1972, H-2 linked immune response (Ir) genes: Independent loci for Ir-IrG and Ir-IrA genes, J. Exp. Med. 122:517.Google Scholar
  35. Mann, D. L., and Fahey, J. L., 1971, Histocompatibility antigens, Ann. Rev. Microbiol. 25:679.CrossRefGoogle Scholar
  36. Manson, L. A., Goldstein, L., Thorn, R., and Palmer, J., 1975, Immune response against apparently host compatible transplantable tumors, Transplant. Proc. VII: 161.Google Scholar
  37. Martyré, M. C., Halle-Pannenko, O., and Jolles, P., 1973, Characterization and partial purification of normal and tumor associated transplantation antigens of Rauscher leukemia cells, Eur. J. Cancer 9:757.PubMedGoogle Scholar
  38. Maurer, B. A., Dean, J. H., Mccoy, J. L., Appella, E., and Law, L. W., Assessment of cell-mediated immunity in mice against PPD, soluble H-2 alloantigens and SV-40 tumor antigens. (Submitted to Cellular Immunology).Google Scholar
  39. Mcdevitt, H. O., and Sela, M., 1965, Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens, J. Exp. Med. 122:517.PubMedCrossRefGoogle Scholar
  40. Meltzer, M. S., Leonard, E. J., Rapp, H. J., and Boros, T., 1971, Tumor-specific antigen solubilized by hypertonic KCl, J. Natl. Cancer Inst. 47:703.PubMedGoogle Scholar
  41. Merino, F., Abeyounis, C. J., and Milgrom, F., 1973, Theta antigen on a murine lymphosarcoma, Transplant. Proc. 5:975.PubMedGoogle Scholar
  42. Morton, D. L., Miller, G. F., and Wood, D. A., 1969, Demonstration of tumor-specific immunity against antigens unrelatèd to the mammary tumor virus, J. Natl. Cancer Inst. 42:290.Google Scholar
  43. Nathenson, S. G., 1970, Biochemical properties of histocompatibility antigens, Ann. Rev. Genet. 4:69.PubMedCrossRefGoogle Scholar
  44. Natori, T., Tanigaki, N., and Pressman, D., 1975a, The 11,000-dalton fragment of mouse H-2 antigen: Isolation and identification, Transplantation 18:550.CrossRefGoogle Scholar
  45. Natori, T., Tanigaki, N., Pressman, D., Henriksen, O., Appella, E., Law, L. W., 1975b, Two components of papain-solubilized H-2 antigen molecules, Immunogenetics (submitted).Google Scholar
  46. Neaport-Santes, C., Lilly, F., Silvestre, D., and Kourilsky, F. M., 1973, Independence of H-2K and H-2D antigenic determinants on the surface of mouse lymphocytes, J. Exp. Med. 137:511.CrossRefGoogle Scholar
  47. Oettgen, H. F., Old, L. J., Mclean, E. P., and Carswell, E. A., 1968, Delayed hypersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in guinea pigs, Nature (London) 220:293.CrossRefGoogle Scholar
  48. Potter, C. W., and Oxford, J. S., 1970, Transplantation immunity following immunization with extracts of adenovirus 12 tumour cells, Int. J. Cancer 6:410.PubMedCrossRefGoogle Scholar
  49. Prager, M. D., Hollinshead, A. C., Ribble, R. J., and Derr, I., 1973, Induction of immunity to a mouse lymphoma by multiple methods, including vaccination with soluble membrane fractions, J. Natl. Cancer Inst. 51:1603.PubMedGoogle Scholar
  50. Rask, L., Lindblom, J. B., and Peterson, P. A., 1974, Subunit structure of H-2 alloantigens, Nature (London) 249:833.CrossRefGoogle Scholar
  51. Schwartz, B. D., Kato, K., Cullen, S. E., and Nathenson, S. G., 1973, H-2 histocompatibility alloantigens: Some biochemical properties of the molecules solubilized by NP-40 detergent, Biochemistry 12:2157.PubMedCrossRefGoogle Scholar
  52. Shimada, A., and Nathenson, S. G., 1969, Murine histocompatibility-2 (H-2) alloantigens: Purification and some chemical properties of soluble products from H-2b and H-2d genotypes released by papain digestion of membrane fractions, Biochemistry 8:4048.PubMedCrossRefGoogle Scholar
  53. Shreffler, D. C., and Klein, J., 1970, Genetic organization and gene action of mouse H-2 region, Transplant. Proc. 2:5.PubMedGoogle Scholar
  54. Silver, J., and Hood, L., 1974, Detergent-solubilized H-2 alloantigen is associated with a small molecular weight polypeptide, Nature (London) 249:764.CrossRefGoogle Scholar
  55. Smith, R. W., Morganroth, J., and Mora, P. T., 1970, SV40 virus-induced tumour specific transplantation antigen in cultured mouse cells, Nature (London) 227:141.CrossRefGoogle Scholar
  56. Snell, G., 1974, Immunogenetics: Retrospect and prospect, Immunogenetics 1:4.CrossRefGoogle Scholar
  57. Snell, G. D., Cherry, M., and Demant, P., 1971, Evidence that H-2 private specificities can be arranged in two mutually exclusive systems possibly homologous with two subsystems of HL-A, Transplant. Proc. 3:183.PubMedGoogle Scholar
  58. Steele, Jr., G., and Sjogren, H., 1974, Cross-reacting tumor-associated antigen(s) among chemically induced rat colon carcinomas, Cancer Res. 34:1801.PubMedGoogle Scholar
  59. Strober, S., Appella, E., and Law, L. W., 1970, Serologic and immunogenic activity of mouse transplantation antigens controlted by the H-2 locus, Proc. Natl. Acad. Sci. U.S.A. 67:765.PubMedCrossRefGoogle Scholar
  60. Suter, L., Bloom, B. R., Wadsworth, E. M., and Oettgen, H. F., 1972, Use of the macrophage migration inhibition test to monitor fractionation of soluble antigens of chemically induced sarcomas of guinea pigs, J. Immunol. 109:766.PubMedGoogle Scholar
  61. Tanigaki, N., Katagiri, M., Nakamuro, K., Kreiter, V. P., and Pressman, D., 1974, II. Small fragments derived from papain-solubilized HL-A antigen molecules, Immunology 26:155.PubMedGoogle Scholar
  62. Thomson, D. M. P., Sellers, V., Eccles, S., and Alexander, P., 1973, Radioimmunoassay of tumour-specific transplantation antigen of a chemically induced rat sarcoma: Circulating soluble tumour antigen tumour bearers, Br. J. Cancer 28:377.PubMedCrossRefGoogle Scholar
  63. Ting, C. C., Lavrin, D. H., Shiu, G., and Herberman, R. B., 1972, Expression of fetal antigens in tumor cells, Proc. Natl. Acad. Sci. U.S.A. 69:1664.PubMedCrossRefGoogle Scholar
  64. Wright, P. W., Law, L. W., Appella, E., and Bernstein, I. D., 1974, Absence of serum blocking activity in mice immunologically tolerant to soluble histocompatibility-2 antigens, Transplantation 17:524.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • Lloyd W. Law
    • 1
  • Ettore Appella
    • 1
  1. 1.Laboratory of Cell BiologyNational Cancer InstituteBethesdaUSA

Personalised recommendations